Inventor · disambiguated record
Michelle Arkin
Also filed as: ARKIN MICHELLE · ARKIN MICHELLE R · ARKIN MICHELLE ROSE
11 granted patents·11 pending applications·82 citations·filing 2001–2021
88Inventor score
Files withSUNESIS PHARMACEUTICALS INC8UNIV CALIFORNIA6UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION2AKASSOGLOU KATERINA1ARKIN MICHELLE1
Top patents by PatentIndex Score
22 records- 0192US7968565B2Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acidSUNESIS PHARMACEUTICALS INC·Filed 2005·Granted Jun 28, 2011·33 cites·1 claims
- 0289US9708247B2Modulators of the eIF2alpha pathwayUNIV CALIFORNIA·Filed 2015·Granted Jul 18, 2017·14 cites·6 claims
- 0386US6806279B2Small-molecule inhibitors of interleukin-2SUNESIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 19, 2004·23 cites·19 claims
- 0484US10343981B2Modulators of the eIF2alpha pathwayUNIV CALIFORNIA·Filed 2017·Granted Jul 9, 2019·6 cites·7 claims
- 0584US8822493B2SNS-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2013·Granted Sep 2, 2014·5 cites·11 claims
- 0674US9980949B2SNS-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2014·Granted May 29, 2018·1 cites·7 claims
- 0769US11220477B2Modulators of the eIF2alpha pathwayUNIV CALIFORNIA·Filed 2019·Granted Jan 11, 2022·0 cites·4 claims
- 0866US2018316309A1Sns-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0961US11099172B2In vitro assays for inhibition of microglial activationTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADSTONE·Filed 2018·Granted Aug 24, 2021·0 cites·6 claims
- 1059US11247985B2Phenyl indole allosteric inhibitors of P97 ATPaseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Granted Feb 15, 2022·0 cites·8 claims
- 1157US2011263524A1Sns-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 1256US2006063795A1SNS-595 and methods of using the sameARKIN MICHELLE·Filed 2005·Application pending·0 cites
- 1353US10633370B2Phenyl indole allosteric inhibitors of p97 ATPaseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Apr 28, 2020·0 cites·11 claims
- 1453US2014205680A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1553US2025263366A2Caspase 6 inhibitors and uses thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1651US2018098975A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1750US2021330611A1Therapy for neurological diseases/disordersAKASSOGLOU KATERINA·Filed 2021·Application pending·0 cites
- 1850US2017003280A1In vitro assays for inhibition of microglial activationTHE J DAVID GLADSTONE INST·Filed 2015·Application pending·0 cites
- 1949US2023052528A1Taspase1 inhibitors and uses thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2047US2003235862A1Methods of characterizing molecular interaction sites on proteinsFiled 2003·Application pending·0 cites
- 2141US2003186464A1Surface plasmon resonance methodsFiled 2003·Application pending·0 cites
- 2237US11413278B2Compounds and methods for promoting stress resistanceUNIV CALIFORNIA·Filed 2016·Granted Aug 16, 2022·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Michelle Arkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →